Burkett Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$731K Buy
2,019
+15
+0.7% +$5.13K 0.23% 31
2026
Q1
$705K Sell
2,004
-18
-0.9% -$6.42K 0.24% 31
2025
Q4
$662K Buy
2,022
+1
+0% +$317 0.23% 32
2025
Q3
$570K Buy
2,021
+57
+3% +$16.5K 0.2% 34
2025
Q2
$548K Sell
1,964
-24
-1% -$6.8K 0.2% 34
2025
Q1
$619K Sell
1,988
-5
-0.3% -$1.48K 0.25% 30
2024
Q4
$520K Sell
1,993
-162
-8% -$48.1K 0.21% 32
2024
Q3
$694K Buy
2,155
+26
+1% +$8.51K 0.29% 30
2024
Q2
$665K Buy
2,129
+15
+0.7% +$4.41K 0.34% 27
2024
Q1
$601K Buy
2,114
+18
+0.9% +$5.27K 0.31% 28
2023
Q4
$604K Buy
+2,096
New +$571K 0.34% 28

Other funds holding AMGN

Burkett Financial Services's AMGN Position: Q2 2026 in Review

Burkett Financial Services increased its Amgen (AMGN) stake by 0.75% in Q2 2026, buying an estimated $5.13K and bringing the position to 2,019 shares worth $731K. The position accounts for 0.23% of the portfolio, ranked #31.

Burkett Financial Services first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Burkett Financial Services held 2,019 shares of Amgen worth $731K as of Q2 2026.
  • Burkett Financial Services bought 15 Amgen shares in Q2 2026, an estimated $5.13K.
  • Amgen made up 0.23% of Burkett Financial Services's portfolio in Q2 2026, its #31 holding.
  • Burkett Financial Services first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,453 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Burkett Financial Services's 13F filing for Q2 2026, filed 2 Jul 2026.